✦ LIBER ✦

Prevalence of metabolic syndrome with international diabetes federation criteria and ATP III program in patients 65 years of age or older

✍ Scribed by D. A. De Luis; R. Lopez Mongil; M. Gonzalez Sagrado; J. A. Lopez Trigo; P. F. Mora; J. Castrodeza Sanz; Group Novomet

Book ID: 107671010
Publisher: Springer
Year: 2010
Tongue: English
Weight: 124 KB
Volume: 14
Category: Article
ISSN: 1279-7707
DOI: 10.1007/s12603-010-0087-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevalence of metabolic syndrome in adul

Prevalence of metabolic syndrome in adults with excess of adiposity: comparison of the Adult Treatment Panel III criteria with the International Diabetes Federation definition

✍ M. González-Ortiz; E. Martínez-Abundis; O. Jacques-Camarena; S. O. Hernández-Gon 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 48 KB

New International Diabetes Federation (I

New International Diabetes Federation (IDF) and National Cholesterol Education Program Adult Treatment panel III (NCEP-ATPIII) criteria and the involvement of hemostasis and fibrinolysis in the metabolic syndrome

✍ I. MERTENS; L. F. VAN GAAL 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Results of intensive chemotherapy in 998

Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: : Predictive prognostic models for outcome

✍ Hagop Kantarjian; Susan O'Brien; Jorge Cortes; Francis Giles; Stefan Faderl; Eli 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views

## Abstract ## BACKGROUND Elderly patients (age ≥ 65 years) with acute myeloid leukemia (AML) generally have a poor prognosis. AML‐type therapy results are often derived from studies in younger patients and may not apply to elderly AML. Many investigators and oncologists advocate, at times, only s